Capture Vascular | January 21, 2015: ATTRACT Trial on DVT Treatment Completes Enrollment
17083
single,single-post,postid-17083,single-format-standard,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

January 21, 2015: ATTRACT Trial on DVT Treatment Completes Enrollment

January 21, 2015: ATTRACT Trial on DVT Treatment Completes Enrollment

The ATTRACT trial will determine if the use of pharmacomechanical catheter-directed thrombolysis in patients with acute proximal deep vein thrombosis (DVT) prevents post thrombotic syndrome and improves quality of life. The results, expected in 2016/2017, has the potential to change the standard of care from anticoagulation to more aggressive catheter directed therapy to improve recovery time and lessen the incidence of Post Thrombotic Syndrome, pulmonary embolism, and other conditions associated with DVT. Capture Vascular is poised to capitalize on this evolution with a system that removes thrombus with an ‘en bloc’ method rather than the inefficient fragmentation techniques utilized by the current thrombectomy devices.

http://evtoday.com/2015/01/21/attract-trial-on-dvt-treatment-completes-enrollment

No Comments

Sorry, the comment form is closed at this time.